NeuroSense Therapeutics Ltd. ( NRSNW) - Stock Earnings
NRSNW Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Sept. 2, 2026, midnight | — / — | — | — / — | — |
NRSNW Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | -1.8 million USD | — USD |
| 2025Q1 | -2.4 million USD | — USD |
| 2025Q2 | -2.4 million USD | — USD |
NRSNW Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.1 million USD | — USD |
| 2024 | -10.2 million USD | — USD |
| 2025 | -11.1 million USD | — USD |
| 2026 Est. | — | — |
NRSNW
Price: $0.04
52 week price:
Earnings Per Share: -0.94 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 3227
Market Capitalization: 2.9 million